Development of a Fluorescent Multiplex Assay for Detection of MSI‐High Tumors
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Determining whether a tumor exhibits microsatellite instability (MSI) is useful in identifying patients with hereditary non‐polyposis colorectal cancer and sporadic gastrointestinal cancers with defective DNA mismatch repair (MMR). The assessment of MSI status aids in establishing a clinical prognosis and may be predictive of tumor response to chemotherapy. A reference panel of five markers was suggested for MSI analysis by a National Cancer Institute (NCI) workshop in 1997 that has helped to standardize testing. But this panel of markers has limitations resulting from the inclusion of dinucleotide markers, which are less sensitive and specific for detection of tumors with MMR deficiencies compared to other types of markers that are currently available. This study demonstrates that mononucleotides are the most sensitive and specific markers for detection of tumors with defects in MMR and identifies an optimal panel of markers for detection of MSI‐H tumors. A set of 266 mono‐, di‐, tetra‐ and penta‐nucleotide repeat microsatellite markers were used to screen for MSI in colorectal tumors. The best markers for detection of MSI‐H tumors were selected for a MSI Multiplex System, which included five mononucleotide markers: BAT-25, BAT-26, NR-21, NR-24 and MONO-27. In addition, two pentanucleotide markers were added to identify sample mix‐ups and/or contamination. We classified 153 colorectal tumors using the new MSI Multiplex System and compared the results to those obtained with a panel of 10 microsatellite markers combined with immunohistochemical (IHC) analysis. We observed 99% concordance between the two methods with nearly 100% accuracy in detection of MSI‐H tumors. Approximately 5% of the MSI‐H tumors had normal levels of four MMR proteins and as a result would have been misclassified based solely on IHC analysis, emphasizing the importance of performing MSI testing. The new MSI Multiplex System offers several distinct advantages over other methods of MSI testing in that it is both extremely sensitive and specific and amenable to high‐throughput analysis. The MSI Multiplex System meets the new recommendations proposed at the recent 2002 NCI workshop on HNPCC and MSI testing and overcomes problems inherent to the original five‐marker panel. The use of a single multiplex fluorescent MSI assay reduces the time and costs involved in MSI testing with increased reliability and accuracy and thus should facilitate widespread screening for microsatellite instability in tumors of patients with gastrointestinal cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“STR loci are known to vary in the presence of microsatellite instability, with the degree of variability depending on the locus being assessed.16,28,43”
From Match criteria for human cell line authentication: Where do we draw the line? (2013) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Self-citationUmar, A., Boland, C. R., Terdiman, J. P., Syngal, S., Chapelle, A. D. L., Ruschoff, J., Fishel, R., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,183
Self-citationMicrosatellite Instability in Cancer of the Proximal Colon
Thibodeau, S. N., Bren, G., & Schaid, D. (1993) · Science · doi:10.1126/science.8484122 · Cited by 3,130 · cited 2×
“ity (MSI), which is characterized by alterations in the length of short tandem repeats in tumor DNA [1,16,44].”
BackgroundResultSelf-citationThe human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
Fishel, R., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J., Kane, M., & Kolodner, R. (1993) · Cell · doi:10.1016/0092-8674(93)90546-3 · Cited by 2,873 · cited 1×
“Microsatellite instability is caused by DNA mismatch repair (MMR) deficiency and subsequent failure to repair errors introduced during replication of DNA [6,11, 22].”
BackgroundClues to the Pathogenesis of Familial Colorectal Cancer
Aaltonen, L. A., Peltomäki, P., Leach, F. S., Sistonen, P., Pylkkänen, L., Mecklin, J.-P., Järvinen, H., Powell, S. M., Jen, J., Hamilton, S. R., et al. (1993) · Science · doi:10.1126/science.8484121 · Cited by 2,710 · cited 2×
“MSI-H tumors are more likely to have mutations in genes with short repetitive tracts includingTGF-βRII, BAX, IGF2R genes [27,30, 32,34,42,50] and less likely to have loss of APC [1,15, 31,38] or have mutations in p53 [1,7,24,31,38,41] and K-ras genes [1,24,31,38].”
BackgroundIonov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D., & Perucho, M. (1993) · Nature · doi:10.1038/363558a0 · Cited by 2,708 · cited 1×
“ity (MSI), which is characterized by alterations in the length of short tandem repeats in tumor DNA [1,16,44].”
BackgroundMutations of a mutS homolog in hereditary nonpolyposis colorectal cancer
Leach, F. S., Nicolaides, N. C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R., Peltomäki, P., Sistonen, P., Aaltonen, L. A., Nyström-Lahti, M., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90330-s · Cited by 2,276 · cited 1×
“Microsatellite instability is caused by DNA mismatch repair (MMR) deficiency and subsequent failure to repair errors introduced during replication of DNA [6,11, 22].”
BackgroundInactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,270 · cited 1×
“MSI-H tumors are more likely to have mutations in genes with short repetitive tracts includingTGF-βRII, BAX, IGF2R genes [27,30, 32,34,42,50] and less likely to have loss of APC [1,15, 31,38] or have mutations in p53 [1,7,24,31,38,41] and K-ras genes [1,24,31,38].”
BackgroundRibic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
Self-citationBronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., et al. (1994) · Nature · doi:10.1038/368258a0 · Cited by 2,052 · cited 1×
“Microsatellite instability is caused by DNA mismatch repair (MMR) deficiency and subsequent failure to repair errors introduced during replication of DNA [6,11, 22].”
Background
Cited by
Items 201–300 of 300
Khaligh, A., Fazeli, M. S., Mahmoodzadeh, H., Mehrtash, A., Kompanian, S., Zeinali, S., & Teimoori‐Toolabi, L. (2021) · Cancer Biomarkers · doi:10.3233/cbm-203226 · Cited by 4
“A clinically in-use MSI analyzing system has been introduced in 2004 composing of five mononucleotide repeats, BAT-25, BAT-26, NR-21, NR-24, and MONO-27 [9].”
Molecular biology of colorectal cancer in clinical practice
Kit, O. I., & Vodolazhsky, D. I. (2015) · Molecular Biology · doi:10.1134/s0026893315040081 · Cited by 4
Análisis de la inestabilidad de microsatélites en el carcinoma escamoso de laringe
Martínez, J. G., Pérez‐Escuredo, J., García‐Carracedo, D., Alonso‐Guervós, M., Suárez-Nieto, C., Llorente, J. L., Álvarez‐Marcos, C., & Hermsen, M. A. J. A. (2011) · Acta Otorrinolaringológica Española · doi:10.1016/j.otorri.2011.07.005 · Cited by 4
Analysis of Microsatellite Instability in Laryngeal Squamous Cell Carcinoma
Martínez, J. G., Pérez‐Escuredo, J., García‐Carracedo, D., Alonso‐Guervós, M., Suárez-Nieto, C., Llorente, J. L., Álvarez‐Marcos, C., & Hermsen, M. A. J. A. (2012) · Acta Otorrinolaringologica (English Edition) · doi:10.1016/j.otoeng.2012.03.006 · Cited by 4
Genomic Alterations in DNA Mismatch Repair Genes Across Different Cancer Types
Holla, V. R., Kahle, M., Kim, S., Ronaghy, A., Yang, R. K., Patel, K. P., Routbort, M. J., Overman, M. J., Dumbrava, E. E. I., Shaw, K. R. M., et al. (2024) · JCO Precision Oncology · doi:10.1200/po-24-00419 · Cited by 3
Adorisio, R., Troncone, G., Barberis, M. C. P., & Pepe, F. (2024) · Journal of Molecular Pathology · doi:10.3390/jmp5020012 · Cited by 3
“The LMR MSI Analysis System (Promega) represents a PCR-based technique able to detect MSI status in diagnostic specimens from solid tumor patients [42,43].”
MethodCircular RNA in Chemonaive Lymph Node Negative Colon Cancer Patients
van den Berg, I., Smid, M., van den Braak, R. R. J. C., van Deurzen, C. H. M., de Weerd, V., Foekens, J. A., IJzermans, J. N. M., Martens, J. W. M., & Wilting, S. M. (2021) · Cancers · doi:10.3390/cancers13081903 · Cited by 3
“In short, the MSI analyses made use of the MSI Analysis System from Promega©, which is a fluorescent PCR-based assay for detection of microsatellite instability in seven markers, including five mononucleotide repeat markers (BAT-25, BAT-26, NR-21, NR-24 and MONO-27) and two pentanucleotide repeat markers (Penta C and…”
MethodHuang, W., Ho, C., Lee, C., Chen, W.-L., Yang, S.-C., Chow, N., & Chen, Y. (2023) · PLoS ONE · doi:10.1371/journal.pone.0284227 · Cited by 3
“A marker was considered positive (unstable) if the shift was equal to or larger than 3 bp in the major band or if new minor bands were present compared with those for the non-tumourous tissue (Fig 1B) [30].”
Chen, W., Yan, Y. H., Young, B., Pinto, A., Jiang, Q., Song, N., Yaseen, A., Yao, W., Zhang, D. Y., & Zhang, J. X. (2024) · Clinical Chemistry · doi:10.1093/clinchem/hvae045 · Cited by 3
Gastrointestinal Malignancy: Genetic Implications to Clinical Applications
Trembath, H. E., Yeh, J. J., & Lopez, N. (2024) · Cancer treatment and research · doi:10.1007/978-3-031-61238-1_15 · Cited by 3
Reynolds, T., Gordon, M., Monar, G. F., Moon, D., & Moon, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713651 · Cited by 3
“Diagnosing MSI in cancer is currently achieved by examining polymerase chain reaction (PCR) products from a few (typically 5–7) informative microsatellite markers (MSI–PCR) [9,10].”
BackgroundReynolds, T., Bertsche, K., Moon, D., & Moon, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010209 · Cited by 3
“Molecular diagnosis of MSI is relatively simple and currently can be accomplished by examining PCR products amplified by a few (typically 5–7) informative microsatellite markers based on polymerase chain reaction (MSI–PCR) [9,10].”
BackgroundMohymen, N. A., Hanon, B. M., & Mahommod, A. S. (2014) · JOURNAL OF ADVANCES IN BIOTECHNOLOGY · doi:10.24297/jbt.v4i1.1632 · Cited by 3
Fatimata, M., Ka, S., Dem, A., & Mamadou, K. (2015) · Journal of Cancer Research and Experimental Oncology · doi:10.5897/jcreo2015.0122 · Cited by 3
“The two most predictive MSI markers included in the group of markers from the National Cancer Institute and the multiplex assay of Bacher and Suraweera, being the loci BAT-25 and BAT-26 were amplified (Suraweera et al., 2002; Bacher et al., 2004).”
MethodGenetic and epidemiological studies of hereditary colorectal cancer
Cederquist, K. (2005) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 3
Instability in the Penta-C and Penta-D Loci in Microsatellite-Unstable Endometrial Cancer
Yılmaz, A. U., Frankel, W. L., Zhao, W., Suarez, A. A., Chen, W., Coleman, J. F., McElroy, J., Pearlman, R., Goodfellow, P. J., & Hampel, H. (2025) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph22111674 · Cited by 2
“Penta-C and Penta-D are ideal for sample identification in this context because their repeat size is nearly identical in samples taken from the same individual but highly polymorphic in samples taken from different individuals.”
Alzoubi, S. (2013) · doi:10.25560/11581 · Cited by 2
Huang, F.-C., Zhao, L., Xie, H., Han, T., Huang, J. H., Wang, X., Yang, J. H., Hong, Y., Shu, J., Yu, J., et al. (2024) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2024.10.002 · Cited by 2
Fu, X., Huang, J., Fan, X., Wang, C., Deng, W., Tan, X., Chen, Z., Cai, Y., Lin, H., Xu, L., et al. (2023) · Journal of Clinical Pathology · doi:10.1136/jcp-2023-209089 · Cited by 2
Li, I.-C., Chiu, C.-Y., Wu, C., Chi, J.-Y., Jian, S.-R., Wang, S.-W., & Chang, C. L. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.12.019 · Cited by 2
Genetic Testing, an Optimal Strategy for Lynch Syndrome Identification
Hudler, P. (2013) · Springer eBooks · doi:10.1007/978-94-007-6597-9_4 · Cited by 2
Lynch syndrome diagnostics: decision-making process for germ-line testing
Lastra, E., García-González, M. A., Llorente, B., Bernuy, C., Barrio, M. J., Pérez‐Cabornero, L., Durán, M., & Girón, C. G. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0793-3 · Cited by 2
No microsatellite instability using Bethesda panel and revised markers in uterine leiomyomas
Hong, J., Lee, J., Gwon, G., & Kim, D.-K. (2013) · Apmis · doi:10.1111/apm.12232 · Cited by 2
PeakSeeker: a program for interpreting genotypes of mononucleotide repeats
Thompson, J. M., & Salipante, S. J. (2009) · BMC Research Notes · doi:10.1186/1756-0500-2-17 · Cited by 2
Berlin, J. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727697784.793571316 · Cited by 2
Abdollahi, Z., Tabatabaiefar, M. A., Noruzi, M., Miar, P., Kazemi, M., Naimi, A., Emami, M. H., & Zeinalian, M. (2021) · Laboratory Medicine · doi:10.1093/labmed/lmab064 · Cited by 1
Analysis of microsatellite instability in Korean patients with pancreatic cancer
ALAM, M. R., KIM, Y. H., ALHAZMI, A., HAQUE, S., KANG, Y. N., JUNG, H. R., Mi-Yeung, S. O. H. N., & Dae-Kwang, K. I. M. (2021) · Minerva Medica · doi:10.23736/s0026-4806.21.07669-2 · Cited by 1
A Review - Colorectal Cancer, Prevalence, along with Screening, Diagnosis, and Novel Therapies
Imran, M., Shahid, H., Zaheen, B., Qureshi, N. B., & Attique, M. (2021) · International Journal of Sciences: Basic and Applied Research · Cited by 1
Miar, P., Tabatabaiefar, M. A., Abdollahi, Z., Noruzi, M., Kazemi, M., Naimi, A., Emami, M. H., Izadi, S., & Zeinalian, M. (2022) · Advanced Biomedical Research · doi:10.4103/abr.abr_205_21 · Cited by 1
Yermakov, L. M., Kwon, R., & Konnick, E. Q. (2025) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2025.02.005 · Cited by 1
Lin, M.-T., Christenson, E. S., Chen, S., Adams, E., Bayes, M., & Eshleman, J. R. (2025) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaf011 · Cited by 1
Lin, M.-T., Christenson, E. S., Pallavajjala, A., & Eshleman, J. R. (2025) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaf026 · Cited by 1
Mendiola, M., Heredia-Soto, V., Baíllo, A., Ruz‐Caracuel, I., Mena, R., Berjón, A., Escudero, J., Pedregosa, J., Hernandez, A., Feliú, J., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-27895-w · Cited by 1
“2 and OncoMate (BAT-25, BAT-26, NR-21 and MONO-27), and 4 additional LMR markers (BAT-52, BAT-56, BAT-59 and BAT-60) 14 .”
Tsiatis, A. C. (2010) · Pathology Case Reviews · doi:10.1097/pcr.0b013e3181e69995 · Cited by 1
Cancer Predisposition Syndromes of the Gastrointestinal Tract
Hagemann, I. S., & Sepulveda, A. R. (2012) · Molecular pathology library · doi:10.1007/978-1-4614-6015-2_7 · Cited by 1
Pritchard, C. C. (2015) · Cited by 1
van Lier, M. G. (2011) · Cited by 1
Burge, M., Leggett, B., & Whitehall, V. (2015) · Colorectal Cancer · doi:10.2217/crc.15.7 · Cited by 1
Tsuge, S., Ueyama, C., Watanabe, K., Nakamura, H. K., & Takeda, A. (2018) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13604 · Cited by 1
“, Madison, Wisconsin), and using two pentanucleotide repeat markers (PentaC and PentaD) as internal controls.(7) MMR gene screening for MLH1, MSH2, MSH6 and PMS2 was performed in cooperation with FALCO Biosystems (Kyoto, Japan) after obtaining permission from the patient during genetic counseling.”
MethodUpdates on Clinical Trials in Diagnosis and Therapy of Colorectal Cancer
Ullah, F., Mani, H., Wazir, M., Hussain, S., Ali, S., & Ahmad, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-72702-4_1 · Cited by 1
Kuick, C. H., Chen, W. W., Chen, H., Chang, K. T. E., & Mok, Y. (2022) · Journal of Clinical Pathology · doi:10.1136/jcp-2022-208692 · Cited by 1
State of the art: Targeting microsatellite instability in gastrointestinal cancers
Mencel, J., Alves, A., Angelis, V., Gerlinger, M., & Starling, N. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104387 · Cited by 1
Liu, T., Ho, C., Chen, Y.-J., Chen, P.-J., Chen, W., Lee, C., Chow, N., Huang, W., & Chen, Y. (2024) · Oncology Letters · doi:10.3892/ol.2024.14578 · Cited by 1
“L) refers to detection of a singular positive marker and MSS refers to a lack of detected positive markers (38).”
Genetic Mutations in Senegalese Women with Breast Cancer
Mbaye, F. B. R., & Sembène, M. (2025) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2025.26.7.2397 · Cited by 1
“This study investigated the two loci most predictive of MSI (BAT-25 and BAT-26), included in the National Cancer Institute group of markers [29, 30].”
Microsatellite Instability Analysis with GeneMarker
Serensits, T., He, H., Ning, W., & Liu, J. (2007) · Cited by 1
Hereditary colorectal cancer syndromes: Epidemiological studies on Peutz-Jeghers syndrom & Lynch
van Lier, M. G. (2011) · RePub (Erasmus University Rotterdam) · Cited by 1
Inherited and Somatic Genetic factors in Colorectal Cancer Development
Burghel, G. J. (2011) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Microsatellite Instability (MSI) Detection in DNA from FFPE Tissues
Glavač, D., & Nardon, E. (2011) · Springer eBooks · doi:10.1007/978-3-642-17890-0_28
“In order to improve the existing panel, more mononucleotide markers have been tested for germline polymorphisms and several of them showed quasimonomorphic nature [23, 24].”
BackgroundZakout, Y. M.-A. (2014) · EprintsUnife
Molecular staging: Integration of molecular prognostic markers into staging of colon cancer
Hayashi, S., & Jass, J. R. (2005) · Current Colorectal Cancer Reports · doi:10.1007/s11888-005-0004-5
Colorectal carcinoma under microscopy: Patohistology or much more?
Ušaj, S. K., Ivković-Kapicl, T., Panjković, M., Klem, I., & Eri, Ž. (2012) · Acta chirurgica iugoslavica · doi:10.2298/aci1202031k
Hereditary Nonpolyposis Colorectal Cancer and Lynch Syndrome
Grenert, J. P. (2016) · Springer eBooks · doi:10.1007/978-3-319-19674-9_24
Gastrointestinal Malignancy: Genetic Implications to Clinical Applications
Lopez, N., & Yeh, J. J. (2016) · Cancer treatment and research · doi:10.1007/978-3-319-34244-3_19
An investigation of chromosome 20q13 amplification in colorectal cancer
Almasmoum, H. A. (2016) · Nottingham ePrints (University of Nottingham)
Denaturing high performance liquid chromatography (DHPLC) in detection of microsatellite instability
Ravnik‐Glavač, M., Berginc, G., & Glavač, D. (2007) · DOAJ (DOAJ: Directory of Open Access Journals)
Use of immunohistochemical versus microsatellite analyses as markers for colorectal cancer
Tantoğlu, U., Yüksel, S., Akyol, C., Doğan, H., KUTLAY, N. Y., Kuzu, I., Özdağ, H., & Kuzu, M. A. (2017) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2017-0050
“The detection of a difference in one locus was considered as low MSI, while a difference in two or more of the five loci was considered as high MSI [16].”
BackgroundGallon, R., Hayes, C. M., Redford, L., Alhilal, G., O’Brien, O., Waltham, A., Needham, S. J., Arends, M. J., Oniscu, A., Alonso, Á., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/382754
Investigation the role of CD24 in metastatic colorectal cancer
Al-Sulaiman, A. (2018) · Nottingham ePrints (University of Nottingham)
Huang, F.-C., Zhao, L., Xie, H., Huang, J. H., Wang, X., Yang, J. H., Hong, Y., Shu, J., Yu, J., Li, Q. Y., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.22.432191
“Loci with fewer than 7 repeats are less sensitive to signals of MSI than longer repeats (9,20-22).”
BackgroundRevolution in Cancer Immunotherapy and its Perspective
Hazama, S. (2019) · Yamaguchi Medical Journal · doi:10.2342/ymj.68.5
Association Between Microsatellite Instability and 18F-FDG PET/CT Data in Colorectal Cancer PatientsPreprint
Hasbek, Z., Demir, N., Yılmaz, M., Özer, H., Ertürk, S. A., & Babacan, Ö. U. (2022) · Research Square · doi:10.21203/rs.3.rs-1213322/v1
Powers, M. P., & Grenert, J. P. (2011) · Springer eBooks · doi:10.1007/978-3-642-19677-5_27
Tsokos, G. C. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727697784.793570383
Modern diagnostic technologies and molecular therapies in oncogenetics
Personal genetics, B., Sabau, D. I., Bacalbaşa, N., Grigoriu, C., Mihai, B.-M., Georgescu, T. A., Bălescu, I., Gheorghe, C.-M., Salmen, T., & Bohîlțea, R. E. (2021) · Romanian Medical Journal · doi:10.37897/rmj.2021.s6.2
Abdalrahman, N. A., & Mohamad, D. (2024) · Journal of Contemporary Medical Sciences · doi:10.22317/jcms.v10i1.1469
Zhou, T., Chen, L., Guo, J., Zhang, M., Zhang, Y., Cao, S., Lou, F., & Wang, H. (2021) · Figshare · doi:10.6084/m9.figshare.14404036
Shin, G. W., Greer, S., Hopmans, E. S., Grimes, S. M., Lee, H., Zhao, L., Miotke, L. K., Suarez, C. J., Almeda, A. F., Haraldsdóttir, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16575359
Shin, G. W., Greer, S., Hopmans, E. S., Grimes, S. M., Lee, H., Zhao, L., Miotke, L. K., Suarez, C. J., Almeda, A. F., Haraldsdóttir, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16575356
Shin, G. W., Greer, S., Hopmans, E. S., Grimes, S. M., Lee, H., Zhao, L., Miotke, L. K., Suarez, C. J., Almeda, A. F., Haraldsdóttir, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16575353
One-instrument, objective microsatellite instability analysis using high-resolution melt
Bendixen, K. K., Sørensen, S. F., Dazio, G., Hansen, E. E., Eriksen, S. K., Epistolio, S., Merlo, E., Boldorini, R. L., Venesio, T., Movilia, A., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0302274
“In recent years, a panel comprising the mononucleotides BAT25, BAT26, NR21, NR24, and MONO27 has outcompeted the Bethesda panel in terms of performance, and its use in clinical diagnosis is progressively increasing [19, 22, 23].”
BackgroundMethodInfluentialImai, K., Yanagawa, N., Saito, H., Nanjo, H., Wakamatsu, Y., Takashima, S., Matsuo, T., Kuriyama, S., Sugai, T., & Minamiya, Y. (2024) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-024-02099-7
“At present, the use of a polymerase chain reaction (PCR)-based MSI Analysis System (the National Cancer Institute, Pentaplex or Promega panel) to evaluate three to five tumor microsatellite loci is the mainstay for MSI detection in tumors and determination of MSI/MMR status [8–10].”
Zhou, B. B., Wang, Y., Ding, L., Tian, X., Sun, W., Zhang, W., & Liu, Y. (2024) · Oncology Letters · doi:10.3892/ol.2024.14832
“The Promega Corporation MSI analysis system is one of the most widely used commercial PCR assays, consisting of 5 mononucleotide markers for MSI detection, namely BAT‑25, BAT‑26, NR‑21, NR‑24 and MONO‑27 (10).”
Detection of Microsatellite Instability in Endometrial Carcinoma Using a Novel Homopolymer Assay
Nicka, C. M., Green, D. C., Tsongalis, G. J., & Tafe, L. J. (2025) · International Journal of Surgical Pathology · doi:10.1177/10668969241311500
Bergfors, M. (2014) · DiVA (Digitala Vetenskapliga Arkivet)
Chung, Y., Nam, S. K., Chang, H. E., Lee, C. M., Kang, G. H., Lee, H. S., & Park, K. U. (2023) · Figshare · doi:10.6084/m9.figshare.24550061
Zhou, T., Chen, L., Guo, J., Zhang, M., Zhang, Y., Cao, S., Lou, F., & Wang, H. (2021) · Figshare · doi:10.6084/m9.figshare.14404039
Shin, G. W., Greer, S., Hopmans, E. S., Grimes, S. M., Lee, H., Zhao, L., Miotke, L. K., Suarez, C. J., Almeda, A. F., Haraldsdóttir, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16575350
Caracterización Molecular de Cáncer Colorrectal Metacrónico
Tapial, S. (2020) · Library Open Repository (Universidad Complutense Madrid)
Booth, M. E. (2023) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Lacombe, K. A. I. (2009) · The Atrium (University of Guelph)
Susanti, S. (2021) · Nottingham ePrints (University of Nottingham)
Männlein, J., & Sterlacci, W. (2026) · Cancers · doi:10.3390/cancers18030433
“Current standard methods for MSI determination include immunohistochemistry (IHC) for evaluation of MMR protein expression, as well as polymerase chain reaction (PCR), which detects alterations in specific microsatellite loci using established marker panels such as Bethesda or Pentaplex [8,9].”
Chung, J. (2022) · TSpace (University of Toronto)
臨床病理学的・分子学的・免疫学的解析と生存解析に基づくMSI-low 食道胃接合部腺癌の免疫学的特性
Toihata, T. (2021) · Institutional Repositories DataBase (IRDB)
Yilmaz, A., Frankel, W. L., Swanson, B. J., Miller, K., Bacher, J., Bigley, C. J., Nelsen, L., Kalady, M. F., Coleman, J. F., Pearlman, R., et al. (2026) · Current Oncology · doi:10.3390/curroncol33040205
“The Promega MSI Analysis System™, which includes the mononucleotide markers BAT-25, BAT-26, MONO-27, NR-21, and NR-24, has been widely used for MSI detection [1,10,16–18].”
InfluentialSelf-citationImplication de glycosyltransférases dans la tumorigenèse colorectale : POFUT1 et ST3GAL2
Deschuyter, M. (2021) · theses.fr (ABES) · doi:10.70675/a7f48b7dz94d5z4817z897bz5677e68073a8
Apport de l'ADN circulant tumoral dans les cancers digestifs
Evrard, C. (2022) · theses.fr (ABES) · doi:10.70675/e887f785zd2daz4c33za83fzd8d4cd2f9935
Velu, P., & Solomon, J. P. (2026) · Current clinical pathology · doi:10.1007/978-3-032-18790-1_3
Chung, Y., Oh, S., Nam, S. K., Kim, H., Lee, C. M., Kang, G. H., Oh, H. J., Lee, H. S., & Park, K. U. (2026) · Diagnostics · doi:10.3390/diagnostics16101550
“The reference criteria were the results of conventional PCR assay with pentaplex panel, which are currently considered gold standard in molecular analysis [25,26].”
Zhu, J., He, P., Qiu, H., Ying, L., & Chen, J. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1874404
“Current MSI determination relies on surgical specimens or endoscopic biopsy, followed by immunohistochemistry (IHC) for MLH1, MSH2, MSH6, and PMS2, PCR fragment analysis, or next − generation sequencing (9).”
Reduced stutter artifact formation with an engineered thermostable DNA polymerase
Courtney, N. A., Mokry, D. Z., Killoran, M. P., Schnell, K., Zimmerman, K., Knoche, K., Hudson, B. C., Ames, C., Sequeira, P., Lentz, T., et al. (2026) · Forensic Science International Genetics · doi:10.1016/j.fsigen.2026.103606
日本人女性トリプルネガティブ乳癌におけるマイクロサテライト不安定性
Kurata, K. (2020) · Institutional Repositories DataBase (IRDB)
Kakodkar, P., & Wang, H. (2026) · International Journal of Surgical Pathology · doi:10.1177/10668969261478659
Ravnik‐Glavač, M., Berginc, G., & Glavač, D. (2016) · Slovenian Medical Journal
EBILI, H. O. (2022) · Nottingham ePrints (University of Nottingham)
Miyashita, K., Komoda, M., Shioi, S., Koi, Y., Shimokawa, M., Kawakami, H., Oda, S., & Esaki, T. (2026) · Scientific Reports · doi:10.1038/s41598-026-73965-y
Metadata
- Authors
- Bacher, J. W., Flanagan, L. A., Smalley, R. L., Nassif, N. A., Burgart, L. J., Halberg, R. B., Megid, W. M. A., & Thibodeau, S. N.
- Affiliations
- Promega (United States) (US)
- Mayo Clinic (US)
- Corresponding author
- Bacher, Jeffery W.
- Venue
- Disease Markers
- Publisher
- Wiley
- Published
- 2004-01
- Volume
- 20
- Issue
- 4-5
- Pages
- 237-250
- ISSN
- 0278-0240 (ISSN-L)
- 1875-8630
- PMC
- PMC3839403
- OpenAlex
- W2104818405
- Cited by
- 276
- References
- 49
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 15 · 2023: 20 · 2022: 16 · 2021: 33 · 2020: 21 · 2019: 11 · 2018: 19 · 2017: 13 · 2016: 10 · 2015: 11 · 2014: 9 · 2013: 9 · 2012: 10
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Disease Markers (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (CA-76834)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Keywords
- microsatellite instability, mismatch repair deficiency, Lynch syndrome, BAT25, BAT26, colorectal neoplasia, gastrointestinal cancer
- MeSH terms
- Alleles, Colorectal Neoplasms, Hereditary Nonpolyposis, DNA Mutational Analysis, Fluorescent Dyes, Gastrointestinal Neoplasms, Gene Frequency, Humans, Immunohistochemistry, Microscopy, Fluorescence, Mutation, Oligonucleotides, Phenotype, Prognosis, Sensitivity and Specificity, Biomarkers, Tumor, Colorectal Neoplasms, Polymerase Chain Reaction, Microsatellite Repeats, DNA Sequence, Unstable
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.